Vaccination providers are invited to join our Immunisation Working Group to share their valuable insights from a primary care perspective and provide ideas, feedback and suggestions on immunisation programs and strategies.
Why join?
In this group, you will be having discussions with immunisation colleagues from your local Public Health Unit, the CESPHN Immunisation team, and other primary care representatives working within your Local Health District. Primary care representatives include GP, nurse and pharmacist immunisers working in the CESPHN region, within a general practice setting or a community pharmacy.
If you are a GP, nurse, or pharmacist providing vaccination services in a general practice or community pharmacy, we encourage you to submit your expression of interest to join the group and share your valuable insights on vaccination in primary care.
What’s involved?
Roles and responsibilities include attending 2 online meetings (1.5 hours each) per year, participating in discussions and providing your perspective and feedback.
Representatives will be appointed, and be remunerated for their time, in accordance with the terms and conditions outlined in the EIS Representation Policy.
Apply now
If you are interested in participating in our Immunisation Working Group, submit your expression of interest to join. Applications close 30 June 2025.
General practices are encouraged to register for three free GoShare vaccination recall programs. These programs use GoShare to send a personalised SMS from your practice to eligible patients to encourage them to book an appointment.
Registration for the program only takes 15 minutes. Practices can participate in all three programs but must register for each individually below.
Flu vaccine recall for patients aged 65+
The flu vaccine recall program is only available to 20 practices in CESPHN, so be sure to register your interest promptly!
Pneumococcal vaccine recall for patients aged 70+
COVID-19 vaccine recall for patients aged 75+
DVA Veteran Gold Card holders and certain Veteran White Card holders (with specific medical conditions) are eligible to receive a heavily subsidised RSV vaccination under The Repatriation Pharmaceutical Benefits Scheme (RPBS) where clinically recommended.
GPs are required to get prior approval through one of the following methods:
Once approval is received, the RPBS script can be provided, and the vaccine can be dispensed for a cost of $7.70.
The two RSV vaccines registered for use in adults aged 60 and above are Abrysvo and Arexvy with no brand preference. However, only Abrysvo is to be used for pregnant women.
More than 60,000 pregnant women have received the respiratory syncytial virus (RSV) vaccine Abrysvo® since the launch of the Australian Government’s free maternal RSV vaccination program in February of this year. The program has coincided with a substantial 40% drop in RSV cases in young children in Australia, from 45,838 cases between February and May 2024 to 27,921 cases during the same period in 2025.
In addition to the maternal vaccination program, the long-acting RSV monoclonal antibody nirsevimab is available for free to eligible infants under the NSW Health-funded program.
Read Minister Butler’s full media release here.
Source: NCIRS Weekly Jab newsletter 13 June 2025. Subscribe here: ncirs.org.au/user/register.
The Australian Government has released its new National Immunisation Strategy for 2025–2030 to guide Australia’s fight against vaccine-preventable diseases over the next five years. It sets a vision for a healthier Australia through immunisation, by reducing the impact of vaccine-preventable diseases through high uptake of safe, effective and equitable immunisation across the lifespan.
The Department of Health, Disability and Ageing will work with states and territories to implement the strategy. See related resources here.
COVID-19 Vaccine Program update
This report provides an update on Australia’s COVID-19 vaccine uptake in the past 12 months with data broken down by a range of factors.
Have your say on the Australian Immunisation Handbook COVID-19 chapter
The Australian Technical Advisory Group on Immunisation (ATAGI) has announced the public consultation on the COVID-19 vaccine chapter in the Australian Immunisation Handbook. The consultation documents can be accessed here or via the below QR code.
To make a feedback submission, click on the link that reads ‘Online Survey’. Public consultation will close on 11 July 2025
| APPLY HERE 28-30 August 2025 Q Station Sydney, Australia Applications close 11:59pm AEST 29 June 2025 | NCIRS Australian Vaccinology Course NCIRS invites you to apply for the Centre’s inaugural Australian Vaccinology Course – a new in-person program informed and delivered by leading Australian and international immunisation experts. Held over three days at one of Sydney’s prime locations, this immersive program is designed for professionals seeking a deep, evidence-based understanding of vaccines, immunology and vaccination programs. Source: NCIRS Weekly Jab newsletter 13 June 2025. Subscribe here: ncirs.org.au/user/register |
| WATCH HERE | GPs and Pharmacists: a unified approach to travel vaccination As international travel returns to pre-COVID levels, many travellers are opting to delay or forgo vaccinations due to perceived low risk, financial concerns, and accessibility issues. Join general practitioner (GP) Dr Ginni Mansberg and pharmacist Christine Kelly in this 30-minute video exploring the evolving collaboration between pharmacists and GPs in delivering travel vaccination services. |
Health Referral Forms
